{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:41:13Z","timestamp":1788388873392,"version":"build-2803163510"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000866","name":"IAVI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Hepatitis B (HBV) prevalence remains high in Sub Saharan Africa and among some key populations such as those with continued exposure through sexual contact. We assessed the HBV status among potential participants who were screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We conducted a cross sectional analysis of data collected from individuals who were screened in Kenya (Nairobi) and Uganda (Entebbe and Kampala). The studies followed hypothetical procedures of an HIV vaccine efficacy trial and aimed to enroll HIV negative key and vulnerable populations at elevated risk of HIV acquisition. HBV status was the main outcome categorized using Hepatitis B surface antigen (HBsAg) and total Hepatitis B core antibody (HBcAb). Baseline characteristics potentially associated with never being infected were analyzed using logistic regression.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>We screened 1,366 participants with mean age (SD) 28.7 (7.3) years. Overall, 46.6% were from Entebbe, 50.7% had secondary or higher level of education, 76.4% had informal high-risk jobs and 56.3% were male. Kampala had only female participants contributing 60.6% of females screened. Of the screened participants, 94.7% and 3.4% were negative and positive for HBsAg respectively. The prevalence on HBV infection was 3.9% among males and 2.8% among females while prevalence by site was: Entebbe (4.9%); Kampala (4.1%) and Nairobi (0.3%). The highest HBV prevalence was found among participants aged 25-29-years (5.2%), those with primary level education (4.5%), and those in informal low risk jobs (6.5%). Considering 1265 participants with complete data on HBsAg and HBcAb-Total, HBV status was never infected (67.9%), past infection (28.5%), chronic infection (3.2%) and acute infection (0.5%). Of 859 who were never infected, 685 (79.7%) were tested for anti-HBs titers of whom 60 (8.8%) had titers &gt;10IU\/L (immune due to vaccination). The odds of never being HBV infected were lower among older individuals 25\u201329 years (AOR 0.51; 95%CI 0.36\u20130.71) and \u226530 years (AOR 0.35; 95% CI 0.25\u20130.49). The odds were higher among participants with informal high-risk jobs from Kampala (AOR 2.21; 95% CI 1.41\u20133.47) and Nairobi (AOR 2.61; 95% CI 1.72\u20134.00) compared to those from Entebbe.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>HBV prevalence and immunity due to vaccination were low among HIV negative individuals who are eligible for HIV vaccine trials and prevalence varies by age, education level and main occupation. Younger individuals and those recruited from existing cohorts\/ clinics have a higher likelihood of having no prior HBV infection. HIV prevention intervention trials are a platform to identify individuals that need HBV vaccination.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0288604","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T17:28:52Z","timestamp":1689614932000},"page":"e0288604","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0414-1818","authenticated-orcid":true,"given":"Yunia","family":"Mayanja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasima","family":"Rida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Kimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ssetala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Mpendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"Nanvubya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaudensia","family":"Mutua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omu","family":"Anzala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt A.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"pone.0288604.ref001","unstructured":"World Health Organization. Hepatitis B Fact Sheet, 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"issue":"9","key":"pone.0288604.ref002","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, Regional, and National burden of Hepatitis B, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019.","volume":"7","author":"BS Sheena","year":"2022","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"pone.0288604.ref003","unstructured":"World Health Organization. Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2021. 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240027077."},{"issue":"06","key":"pone.0288604.ref004","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3855\/jidc.591","article-title":"Hepatitis B virus infections in apparently healthy urban Nigerians: data from pre-vaccination tests","volume":"4","author":"MP Adoga","year":"2010","journal-title":"J Infect Dev Ctries"},{"issue":"3","key":"pone.0288604.ref005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7196\/SAMJ.6097","article-title":"Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.","volume":"103","author":"H Guimar\u00e3es Nebenzahl","year":"2013","journal-title":"SAMJ: South African Medical Journal"},{"issue":"1","key":"pone.0288604.ref006","article-title":"Prevalence of Hepatitis B virus co-infection among HIV-seropositive persons attending antiretroviral clinics in the Eastern Region of Ghana","volume":"25","author":"G Kye-Duodu","year":"2016","journal-title":"The Pan African Medical Journal"},{"issue":"1","key":"pone.0288604.ref007","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1186\/1471-2458-13-727","article-title":"High burden of hepatitis B infection in Northern Uganda: results of a population-based survey","volume":"13","author":"E Ochola","year":"2013","journal-title":"BMC Public Health"},{"issue":"1","key":"pone.0288604.ref008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/QAI.0000000000000368","article-title":"HIV and STI prevalence and risk factors among male sex workers and other men who have sex with men in Nairobi, Kenya.","volume":"68","author":"N Muraguri","year":"2015","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"4","key":"pone.0288604.ref009","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/OLQ.0b013e3182099545","article-title":"HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behaviour in Kampala, Uganda","volume":"38","author":"J Vandepitte","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"7","key":"pone.0288604.ref010","doi-asserted-by":"crossref","first-page":"e0132287","DOI":"10.1371\/journal.pone.0132287","article-title":"Co-infection burden of hepatitis C virus and human immunodeficiency virus among injecting heroin users at the Kenyan Coast","volume":"10","author":"RS Mwatelah","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"pone.0288604.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05359-y","article-title":"Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017)","volume":"20","author":"A Scheibe","year":"2020","journal-title":"BMC Infect Dis"},{"key":"pone.0288604.ref012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-09012-w","article-title":"Prevalence and risk factors associated with HIV\/hepatitis B and HIV\/hepatitis C co-infections among people who inject drugs in Mozambique","volume":"20","author":"C Sem\u00e1 Baltazar","year":"2020","journal-title":"BMC Public Health"},{"issue":"2","key":"pone.0288604.ref013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/infdis\/jir720","article-title":"Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters","volume":"205","author":"HM Chun","year":"2012","journal-title":"J Infect Dis"},{"issue":"7","key":"pone.0288604.ref014","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/infdis\/jit299","article-title":"Hepatitis B virus (HBV) coinfection accelerates immunologic progression in patients with primary HIV infection in an area of hyperendemicity for HBV infection","volume":"208","author":"MS Tsai","year":"2013","journal-title":"J Infect Dis"},{"issue":"9","key":"pone.0288604.ref015","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/infdis\/jit351","article-title":"Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study","volume":"208","author":"G Wandeler","year":"2013","journal-title":"J Infect Dis"},{"issue":"7","key":"pone.0288604.ref016","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women","volume":"385","author":"RJ Landovitz","year":"2021","journal-title":"N Engl J Med"},{"key":"pone.0288604.ref017","article-title":"HIV Prevention Efficacy Trial Designs of the Future: PrEP Considerations for the MOSAICO Trial","author":"S. Buchbinder","year":"2020","journal-title":"The Global HIV Vaccine Enterprise: Virtual Workshop Series"},{"issue":"1","key":"pone.0288604.ref018","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13256-015-0679-4","article-title":"Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report.","volume":"9","author":"M Malahleha","year":"2015","journal-title":"J Med Case Rep"},{"issue":"3","key":"pone.0288604.ref019","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/QAI.0000000000000857","article-title":"The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals with Active Hepatitis B","volume":"71","author":"MM Solomon","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"pone.0288604.ref020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hep.20110","article-title":"Practice Guidelines Committee AAftSoLD. Chronic hepatitis B: update of recommendations","volume":"39","author":"AS Lok","year":"2004","journal-title":"Hepatology"},{"issue":"725","key":"pone.0288604.ref021","first-page":"1","article-title":"Factors associated with vaccination completion and retention among HIV negative female sex workers enrolled in a simulated vaccine efficacy trial in Kampala, Uganda","volume":"19","author":"Y Mayanja","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"15","key":"pone.0288604.ref022","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.vaccine.2019.02.072","article-title":"Simulated vaccine efficacy trials to estimate HIV incidence for actual vaccine clinical trials in key populations in Uganda","volume":"37","author":"A Abaasa","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"pone.0288604.ref023","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1186\/s12889-020-09932-7","article-title":"Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study","volume":"20","author":"Y Mayanja","year":"2020","journal-title":"BMC Public Health"},{"issue":"8","key":"pone.0288604.ref024","doi-asserted-by":"crossref","first-page":"e0238028","DOI":"10.1371\/journal.pone.0238028","article-title":"Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya","volume":"15","author":"EM Mutisya","year":"2020","journal-title":"PLoS One"},{"key":"pone.0288604.ref025","author":"Uganda National Council for Science and Technology","year":"2014"},{"key":"pone.0288604.ref026","unstructured":"Ministry of Health. Uganda Population Based HIV Impact Assessment (UPHIA) 2016\u20132017: Final Report. 2019. http:\/\/phia.icap.columbia.edu."},{"issue":"3","key":"pone.0288604.ref027","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jvh.13217","article-title":"Prevalence and burden of HBV co\u2010infection among people living with HIV: A global systematic review and meta\u2010analysis","volume":"27","author":"L Platt","year":"2020","journal-title":"J Viral Hepat"},{"key":"pone.0288604.ref028","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jmv.22051","article-title":"Hepatitis B virus and sexual behavior in Rakai, Uganda","volume":"83","author":"L Stanbinsky","year":"2011","journal-title":"J Med Virol"},{"key":"pone.0288604.ref029","first-page":"124","article-title":"Mortality trend due to Hepatitis B and C in the city of S\u00e3o Paulo, 2002\u20132016","volume":"54","author":"APS Sato","journal-title":"Revista de Sa\u00fade P\u00fablica"},{"issue":"1","key":"pone.0288604.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12905-022-02018-z","article-title":"Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers","volume":"22","author":"I Kayesu","year":"2022","journal-title":"BMC Women\u2019s Health"},{"issue":"5","key":"pone.0288604.ref031","doi-asserted-by":"crossref","first-page":"e25909","DOI":"10.1002\/jia2.25909","article-title":"Oral pre\u2010exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study","volume":"25","author":"Y Mayanja","year":"2022","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"pone.0288604.ref032","article-title":"Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey","volume":"9","author":"J Bwogi","year":"2009","journal-title":"African health sciences"},{"key":"pone.0288604.ref033","doi-asserted-by":"crossref","first-page":"321","DOI":"10.35248\/2329-891X.19.7.321","article-title":"Prevalence and factors associated with hepatitis B surface antigen positivity among women receiving antenatal care at Mbarara Regional Referral Hospital","volume":"7","author":"A Hillary","year":"2019","journal-title":"J Trop Dis"},{"key":"pone.0288604.ref034","article-title":"Prevalence and Risk Factors Associated with Hepatitis B and C in Nawabshah, Sindh, Pakistan","author":"AA Samo","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pone.0288604.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06368-1","article-title":"Hepatitis B virus infection among men who have sex with men and transgender women living with or at risk for HIV: a cross sectional study in Abuja and Lagos, Nigeria","volume":"21","author":"OA Adeyemi","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0288604.ref036","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12889-021-10408-5","article-title":"Evaluating the independent influence of sexual transmission on HBV infection in China: a modeling study","volume":"21","author":"M Li","year":"2021","journal-title":"BMC Public Health"},{"issue":"10","key":"pone.0288604.ref037","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2105\/AJPH.90.10.1570","article-title":"Association of Hepatitis B virus infection with other sexually transmitted infections in homosexual men. Omega Study Group","volume":"90","author":"RS Remis","year":"2000","journal-title":"Am J Public Health"},{"issue":"10","key":"pone.0288604.ref038","doi-asserted-by":"crossref","first-page":"e48219","DOI":"10.1371\/journal.pone.0048219","article-title":"Prevalence and factors associated with hepatitis B immunization and infection among men who have sex with men in Beijing, China","volume":"7","author":"C Wang","year":"2012","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T17:29:37Z","timestamp":1689614977000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288604"}},"subtitle":[],"editor":[{"given":"Darrell Eugene","family":"Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0288604","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]}}}